• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑肿瘤患者尿中假尿苷的排泄情况。

Urinary excretion of pseudouridine in patients with brain tumours.

作者信息

Manjula S, Aroor A R, Raja A, Rao S, Rao A

机构信息

Department of Biochemistry, Kastruba Medical College, Manipal, Karnataka, India.

出版信息

Acta Oncol. 1993;32(3):311-4. doi: 10.3109/02841869309093601.

DOI:10.3109/02841869309093601
PMID:8323769
Abstract

Elevated urinary levels of modified nucleosides, especially pseudouridine (psi), have been observed in patients with a variety of malignant neoplasms. In this report, the urinary psi levels were estimated by high performance liquid chromatography in 93 patients with brain tumours and in 40 age and sex matched controls. The psi levels were found to be excreted in equal amounts in the control and the tumour groups. There was no significant difference in psi when patients with malignant diseases were compared with those with benign tumours. Following therapy, the psi levels remained unchanged when compared to the controls and their preoperative values. It is concluded that urinary psi concentration is not a useful marker for brain tumours.

摘要

在患有各种恶性肿瘤的患者中,已观察到尿液中修饰核苷水平升高,尤其是假尿苷(ψ)。在本报告中,通过高效液相色谱法对93例脑肿瘤患者和40例年龄及性别匹配的对照者的尿液ψ水平进行了评估。发现对照组和肿瘤组中ψ的排泄量相等。将恶性疾病患者与良性肿瘤患者相比,ψ水平没有显著差异。治疗后,与对照组及其术前值相比,ψ水平保持不变。结论是尿液ψ浓度不是脑肿瘤的有用标志物。

相似文献

1
Urinary excretion of pseudouridine in patients with brain tumours.脑肿瘤患者尿中假尿苷的排泄情况。
Acta Oncol. 1993;32(3):311-4. doi: 10.3109/02841869309093601.
2
Excretion patterns of pseudouridine and beta-aminoisobutyric acid in patients with tumours of the upper urinary tract.
Scand J Urol Nephrol. 1990;24(4):287-92.
3
Urinary excretion patterns of pseudouridine and beta-aminoisobutyric acid in patients with tumours of the urinary bladder.
Scand J Urol Nephrol. 1993;27(1):45-53. doi: 10.3109/00365599309180413.
4
Evaluation of urinary pseudouridine as a tumor marker in lung cancer.尿假尿苷作为肺癌肿瘤标志物的评估
J Formos Med Assoc. 1994 Jan;93(1):25-9.
5
Correlations of pseudouridine in 8-hour and 24-hour urinary samples determined by high-performance liquid chromatography.通过高效液相色谱法测定的8小时和24小时尿液样本中假尿苷的相关性。
Urol Res. 1982;10(5):245-8. doi: 10.1007/BF00255930.
6
Tailor-Made Molecularly Imprinted Polymer for Selective Recognition of the Urinary Tumor Marker Pseudouridine.定制分子印迹聚合物选择性识别尿肿瘤标志物假尿嘧啶核苷。
Macromol Biosci. 2017 Dec;17(12). doi: 10.1002/mabi.201700250. Epub 2017 Nov 16.
7
Liquid chromatographic determination of urinary 5-methyl-2'-deoxycytidine and pseudouridine as potential biological markers for leukaemia.液相色谱法测定尿中5-甲基-2'-脱氧胞苷和假尿苷作为白血病潜在生物标志物的研究
J Pharm Biomed Anal. 1999 Dec;21(5):1045-51. doi: 10.1016/s0731-7085(99)00221-6.
8
Direct determination of urinary pseudouridine by high-performance liquid chromatography.
Anal Biochem. 1988 May 1;170(2):387-9. doi: 10.1016/0003-2697(88)90648-3.
9
An immunohistochemical analysis for cancer of the esophagus using monoclonal antibodies specific for modified nucleosides.使用针对修饰核苷的单克隆抗体对食管癌进行免疫组织化学分析。
Cancer. 1993 Dec 15;72(12):3571-8. doi: 10.1002/1097-0142(19931215)72:12<3571::aid-cncr2820721205>3.0.co;2-9.
10
Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control.修饰核苷:一种用于癌症临床诊断、早期检测及治疗监测的精确肿瘤标志物。
Br J Cancer. 2006 Jun 5;94(11):1726-33. doi: 10.1038/sj.bjc.6603164.